Polish antitrust watchdog approves Omega-GSK deal 7 years 50 weeks atpakaļ
The Office of Competition and Consumer Protection (UOKiK) on 8 June announced that it had given its approval for Belgian Omega Pharma's proposed acquisition of GlaxoSmithKline ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
GlaxoSmithKline notes 45% profit growth in the Czech Republic 7 years 1 week atpakaļ
In 2011 GlaxoSmithKline (GSK) earned CZK 240m (€9.4m) in the Czech Republic, an increase by 45% compared with the preceding year, CTK news agency reports. At the same time, ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Medicalgorithmics looking to buy heart-impact study firm in the US 7 years 1 week atpakaļ
Medicalgorithmics, the NewConnect-listed maker of innovative remote diagnostic solutions, is eyeing takeover targets among US contract research firms specialised in heart-impact studies for drug makers, ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Polish sales at Sanitas up by 12% in Q1 7 years 1 week atpakaļ
Sanitas, the Lithuanian drug maker owned by Valeant Pharmaceuticals, reported a 12.4% year-on-year increase in sales on the Polish pharmacautical market in the first quarter of ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Sanofi’s Clexane generated the highest reimbursement cost in January-February 2012 7 years 1 week atpakaļ
Clexane (Sanofi) was the single commercial product that generated the highest reimbursement cost for the NFZ in January-February 2012, followed by Seretide Dysk 500 (GlaxoSmithKline) ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Penta wants to purchase pharmacy chains in Poland and Czech Republic 7 years 1 week atpakaļ
Financial group Penta Investments is negotiating the purchase of pharmacy chains in the Czech Republic and Poland, the company’s spokesman Martin Danko told Central Europe ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Genomed reports 31% sales rise in Q1 7 years 52 weeks atpakaļ
Genomed, the NewConnect-listed provider of DNA sequencing analysis and genetic testing services, had a strong first quarter on the revenue front with sales up by 30.6% year-on-year ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
CF Cefarm privatisation falls through as PCZ pulls out 8 years 16 stundas atpakaļ
PCZ, the listed healthcare group, on 30 May announced that it is walking away from the deal to buy CF Cefarm, the last remaining state-owned drug distributor, “due to factors ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Health Ministry explains conditions of prescribed medicine substitution 8 years 16 stundas atpakaļ
The Health Ministry has clarified its interpretation of Article 44, paragraphs 1 and 2 of the Reimbursement Act pertaining to the substitution of prescribed reimbursed medicines. ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Generic and innovative drugs market in CIS countries 2012 8 years 1 dienu atpakaļ
Pharma & Healthcare Market Reports & Trends,Country Risk,Forecasts
Read-Gene launches new supplement 8 years 1 dienu atpakaļ
Read-Gene, the NewConnect-listed start-up specialised in genetic cancer screening and clinical trials, on 21 May inaugurated online sales of SEL-NAT, a new natural selenium supplement. ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Medicalgorithmics secures key FDA approval 8 years 2 dienas atpakaļ
Medicalgorithmics, the NewConnect-listed maker of innovative e-health devices and solutions, on 21 May announced the receipt of marketing authorisation from the US Food and Drug ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Slovak competition watchdog approves Domov Zdravia’s takeover by Penta 8 years 5 dienas atpakaļ
The Antimonopoly Office of the Slovak Republic approved the acquisition of Domov Zdravia by CEE financial group Penta Investments. The decision came into force on 30 April 2012. Domov ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Telemedycyna Polska posts 44% sales growth in Q1 8 years 5 dienas atpakaļ
First-quarter sales at Telemedycyna Polska, Polish provider of remote cardiac services, leapt by 44.2% compared with a year earlier, to PLN 1.33m (€0.3m), and the group moved ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Private healthcare market in Poland 2012 8 years 1 week atpakaļ
Pharma & Healthcare Market Reports & Trends,Country Risk,Forecasts
Parallel importers propose special reimbursement procedure and payback rule 8 years 1 week atpakaļ
The Association of Parallel Importers of Medicinal Products (SIRPL) has announced a proposed amendment to the Reimbursement Act that simplifies the procedure for placing parallel-imported ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Bulgaria considers full reimbursement of therapy for socially significant diseases 8 years 1 week atpakaļ
A drug policy discussion document shows that the Bulgarian Health Ministry and the National Health Insurance Fund (NHIF) are considering options to reimburse the treatment of socially ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Strong results and outlook at Voxel as it prepares to launch PET tracers production 8 years 1 week atpakaļ
Voxel, the NewConnect-listed operator of diagnostic centres, has published a results forecast for this year and next envisioning sales revenues to grow by about 10% in 2012, to PLN ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
Egis reports 15% sales decrease in Poland in January-March 2012 8 years 1 week atpakaļ
Egis, a Hungarian pharmaceutical manufacturer, reported consolidated sales worth €14m on the Polish pharmaceutical market in the second quarter of its 2011/2012 fiscal year, i.e. ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe
New strategy helps IDZ to a 5% sales rise in Q1 8 years 1 week atpakaļ
Sales at Internetowy Dom Zdrowia (IDZ, formerly Domzdrowia.pl), the online health & beauty retailer, rose 5.2% year-on-year in the first quarter of the year, to PLN 2.21m (€0.51m). ...
Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe